Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: A baseline survey

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Khan, Mohiuddin H ^a   Akazawa, Manabu ^a,b   Dararath, Eav ^c   Kiet, Heng B ^c   Sovannarith, Tey ^c   Nivanna, Nam ^c   Yoshida, Naoko ^a   Kimura, Kazuko ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c Ministry of Health Cambodia   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

COUNTERFEIT DRUG;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CAMBODIA; DEVELOPING COUNTRY; DRUG INDUSTRY; FEMALE; FRAUD; HUMAN; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; QUESTIONNAIRE;

ADULT; CAMBODIA; COUNTERFEIT DRUGS; DEVELOPING COUNTRIES; DRUG INDUSTRY; FEMALE; FRAUD; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; QUESTIONNAIRES;

EID: 81055150492     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-306     Document Type: Article

References (22)

1. Police across Southeast Asia target counterfeit medicines in multi-agency operation. http://www.interpol.int/Public/ICPO/PressReleases/PR2008/PR200865. asp
2. Study Report on Counterfeit and Substandard Drugs in Cambodia 2001. MOH, Phnom Penh: Ministry of Health, Cambodia 2001
3. Access to Essential Medicines: Cambodia 2001. MSH, Washington DC Center for Pharmaceutical Management, Management Sciences for Health 2003
4. Cambodian Officials Identify, Pull Counterfeit Drugs from Market. USP, Rockville, MD: The United States Pharmacopeial Convention 2011
5. Drug Quality Assurance: TLC Project Report-Cambodia. MOH, Phnom Penh: Department of Drugs and Food 2006
6. Counterfeit pharmaceuticals: Murder by medicine. Aldhous P, Nature 2005 434 132 136 10.1038/434132a 15758966
7. Counterfeit Medicines in Cambodia - Possible Causes. Khan M, Okumura J, Sovannarith T, Nivanna N, Nagai H, Taga M, Yoshida N, Akazawa M, Tanimoto T, Kimura K, Pharm Res 2011 28 484 489 10.1007/s11095-010-0289-1 20886264
8. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines. Tetteh E, Research in Social and Administrative Pharmacy 2009 5 286 297 10.1016/j.sapharm.2008.08. 001 19733829
9. Wholesalers called weak link in pharmaceutical supply chain. Lewis M, Drug Topics United States 2004
10. MHRA, Anti-counterfeiting strategy 2007-2010 2007
11. Tackling Corruption in the Pharmaceutical Systems Worldwide with Courage and Conviction. Cohen JC, Mrazek M, Hawkins L, Clin Pharmacol Ther 2007 81 445 449 10.1038/sj.clpt.6100074 17251983 (Pubitemid 46364483)
12. The impact of the pharmaceutical regulations on the quality of medicines on the Sudanese market: Importers' perspective. Mohamed GK, Sudanese Journal of Public Health 2007 2 157 167
13. 2nd Study Report on Counterfeit and Substandard Drugs in Cambodia 2004. MOH, Phnom Penh: Ministry of Health, Cambodia 2004
14. Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia. Yang D, Plianbangchang P, Visavarungroj N, Rujivipat S, Southeast Asian J Trop Med Public Health 2004 35 741 747 15689098 (Pubitemid 39486452)
15. Counterfeit and substandard antimalarial drugs in Cambodia. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A, Trans R Soc Trop Med Hyg 2006 100 1019 1024 10.1016/j.trstmh.2006. 01.003 16765399 (Pubitemid 44334726)
16. Prevalence of counterfeit anti-helminthic medicines: a cross-sectional survey in Cambodia. Khan MH, Okumura J, Sovannarith T, Nivanna N, Akazawa M, Kimura K, Trop Med Int Health 2010 15 639 644 20214756
17. Quality control of medicines in the community drug shops in Cambodia. Shimizu K, Okumura J, Akazawa M, Kimura K, Japanese Journal of Social Pharmacy 2010 28 148 149
18. Technical Report Series 902: WHO Expert Committee on Specifications for Pharmaceutical Preparations- Thirty-sixth Report. WHO, Geneva, Switzerland: World Health Organization 2002
19. Drug Wholesaling and Importation: Challenges and Opportunities. Giacalone RP, California Western International Law Journal 2006 36 65
20. Counterfeit Drugs. Rudolf PM, Bernstein IBG, The New England Journal of Medicine 2004 350 1384 1386 10.1056/NEJMp038231 15070787 (Pubitemid 38419991)
21. Patient safety and supply chains. Brady C, Business & Finance Magazine Lesix Nexis 2009 3 3 22081362
22. Technical Report Series 957: WHO Expert Committee on Specifications for Pharmaceutical Preparations (annex 5). WHO, Geneva, Switzerland: World Health Organization 2010